Kalvista Pharmaceuticals Inc (OQ:KALV)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 5th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 7/20 Feb 5/20 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -100 $17.10
Feb 7/20 Feb 5/20 Feener Edward P. Direct Ownership Common Stock S - Open market or private sale -100 $17.11
Feb 7/20 Feb 5/20 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -200 $17.05
Dec 26/19 Dec 20/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,646  
Dec 26/19 Dec 20/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -2,646 $17.02
Dec 26/19 Dec 20/19 Yea Christopher Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,646 $0.004
Dec 26/19 Dec 20/19 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -2,300 $17.02
Dec 16/19 Dec 16/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -3,010  
Dec 16/19 Dec 16/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -3,010 $17.05
Dec 16/19 Dec 16/19 Yea Christopher Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,010 $0.004
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for KALV within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 5th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 7/20 Feb 5/20 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -100 $17.10
Feb 7/20 Feb 5/20 Feener Edward P. Direct Ownership Common Stock S - Open market or private sale -100 $17.11
Feb 7/20 Feb 5/20 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -200 $17.05
Dec 26/19 Dec 20/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,646  
Dec 26/19 Dec 20/19 Yea Christopher Direct Ownership Common Stock S - Open market or private sale -2,646 $17.02
Dec 26/19 Dec 20/19 Yea Christopher Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,646 $0.004
Dec 26/19 Dec 20/19 Crockett Thomas Andrew Direct Ownership Common Stock S - Open market or private sale -2,300 $17.02
Dec 16/19 Dec 16/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -3,010  
Dec 16/19 Dec 13/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,500  
Dec 16/19 Dec 12/19 Yea Christopher Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -199  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $KALV

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Apellis Pharmaceuticals (OQ:APLS)
Aptinyx (OQ:APTX)